https://ir.tcbiopharm.com/news/press-releases/rss en-us https://d1io3yog0oux5.cloudfront.net/tcbiopharm/files/theme/images/logo-sm.png Equisolve Investor Relations Suite https://ir.tcbiopharm.com/news/press-releases/detail/125/tc-biopharm-announces-complete-response-in-minimal-residual Wed, 11 Jun 25 08:30:00 -0400 https://ir.tcbiopharm.com/news/press-releases/detail/125/tc-biopharm-announces-complete-response-in-minimal-residual https://ir.tcbiopharm.com/news/press-releases/detail/124/tcbp-announces-grant-of-european-patent-for-targeting-of Wed, 09 Apr 25 09:00:00 -0400 https://ir.tcbiopharm.com/news/press-releases/detail/124/tcbp-announces-grant-of-european-patent-for-targeting-of https://ir.tcbiopharm.com/news/press-releases/detail/123/tcbp-announces-transition-from-nasdaq-to-otc-markets Fri, 21 Mar 25 10:45:00 -0400 https://ir.tcbiopharm.com/news/press-releases/detail/123/tcbp-announces-transition-from-nasdaq-to-otc-markets https://ir.tcbiopharm.com/news/press-releases/detail/122/tcbp-announces-outsourcing-initiatives-reducing-burn-rate Tue, 18 Mar 25 08:03:00 -0400 https://ir.tcbiopharm.com/news/press-releases/detail/122/tcbp-announces-outsourcing-initiatives-reducing-burn-rate https://ir.tcbiopharm.com/news/press-releases/detail/121/tcbp-announces-non-binding-letter-of-intent-to-acquire Wed, 05 Mar 25 08:30:00 -0500 https://ir.tcbiopharm.com/news/press-releases/detail/121/tcbp-announces-non-binding-letter-of-intent-to-acquire https://ir.tcbiopharm.com/news/press-releases/detail/120/tcbp-ceo-bryan-kobel-to-participate-on-cancer-progress Thu, 20 Feb 25 08:00:00 -0500 https://ir.tcbiopharm.com/news/press-releases/detail/120/tcbp-ceo-bryan-kobel-to-participate-on-cancer-progress https://ir.tcbiopharm.com/news/press-releases/detail/119/tcbp-announces-successful-completion-of-cohort-a-in-the Thu, 13 Feb 25 08:30:00 -0500 https://ir.tcbiopharm.com/news/press-releases/detail/119/tcbp-announces-successful-completion-of-cohort-a-in-the https://ir.tcbiopharm.com/news/press-releases/detail/118/tcbp-announces-successful-completion-of-initial-cohort-b Mon, 10 Feb 25 10:00:00 -0500 https://ir.tcbiopharm.com/news/press-releases/detail/118/tcbp-announces-successful-completion-of-initial-cohort-b https://ir.tcbiopharm.com/news/press-releases/detail/117/tcbp-to-implement-ads-ratio-change Wed, 05 Feb 25 12:00:00 -0500 https://ir.tcbiopharm.com/news/press-releases/detail/117/tcbp-to-implement-ads-ratio-change https://ir.tcbiopharm.com/news/press-releases/detail/116/tcbp-announces-h5n1-proof-of-concept-studies-intention Wed, 15 Jan 25 08:30:00 -0500 https://ir.tcbiopharm.com/news/press-releases/detail/116/tcbp-announces-h5n1-proof-of-concept-studies-intention